AT381319B - Verfahren zur herstellung von neuen derivaten von daunorubicin und doxorubicin - Google Patents

Verfahren zur herstellung von neuen derivaten von daunorubicin und doxorubicin

Info

Publication number
AT381319B
AT381319B AT0260883A AT260883A AT381319B AT 381319 B AT381319 B AT 381319B AT 0260883 A AT0260883 A AT 0260883A AT 260883 A AT260883 A AT 260883A AT 381319 B AT381319 B AT 381319B
Authority
AT
Austria
Prior art keywords
daunorubicin
doxorubicin
producing new
new derivatives
derivatives
Prior art date
Application number
AT0260883A
Other languages
English (en)
Other versions
ATA260883A (de
Inventor
Carol Walker Mosher
George Low Tong
Edward Mc Intosh Acton
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of ATA260883A publication Critical patent/ATA260883A/de
Application granted granted Critical
Publication of AT381319B publication Critical patent/AT381319B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT0260883A 1982-07-20 1983-07-15 Verfahren zur herstellung von neuen derivaten von daunorubicin und doxorubicin AT381319B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40012082A 1982-07-20 1982-07-20
US06/496,122 US4464529A (en) 1982-07-20 1983-05-24 Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin

Publications (2)

Publication Number Publication Date
ATA260883A ATA260883A (de) 1986-02-15
AT381319B true AT381319B (de) 1986-09-25

Family

ID=27016900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0260883A AT381319B (de) 1982-07-20 1983-07-15 Verfahren zur herstellung von neuen derivaten von daunorubicin und doxorubicin

Country Status (24)

Country Link
US (1) US4464529A (de)
KR (1) KR880002461B1 (de)
AT (1) AT381319B (de)
AU (1) AU555902B2 (de)
BE (1) BE897312A (de)
CA (1) CA1239396A (de)
CH (1) CH655729A5 (de)
DE (1) DE3325816A1 (de)
DK (1) DK158269C (de)
ES (2) ES8501415A1 (de)
FI (1) FI75174C (de)
FR (1) FR2530640B1 (de)
GB (1) GB2124224B (de)
GR (1) GR78885B (de)
IE (1) IE55795B1 (de)
IL (1) IL69260A (de)
IT (1) IT1163818B (de)
NL (1) NL188905C (de)
NO (1) NO157146C (de)
NZ (1) NZ204911A (de)
PH (1) PH21860A (de)
PT (1) PT77060B (de)
SE (1) SE459921B (de)
YU (2) YU155083A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826964A (en) * 1982-07-20 1989-05-02 Sri International Bridged oxygen analogs of daunorubcin and doxorubicin
JPS59212499A (ja) * 1983-05-13 1984-12-01 アドリヤ・ラボラトリ−ズ・インコ−ポレ−テツド 抗腫瘍性抗生物質アントラサイクリンの４−デメトキシ−３′−デアミノ−３′（４−モリホリニル）誘導体
GB2140006A (en) * 1983-05-17 1984-11-21 Erba Farmitalia Anthracycline derivatives
US4585859A (en) * 1983-05-24 1986-04-29 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
FR2560876B1 (fr) * 1984-03-09 1987-01-16 Hoechst Lab Nouvelles anthracyclinones, leur procede de preparation, nouveaux glycosides (anthracyclines) obtenus a partir de ces anthracyclinones, utilisation de ces glycosides en tant que medicaments
FR2565982B1 (fr) * 1984-06-15 1988-01-15 Hoechst Lab Nouveaux amino-3-tridesoxy-3,4,6-glycals, leurs procedes de preparation et anthracyclines obtenues a l'aide de ces glycals
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
US4705850A (en) * 1984-10-25 1987-11-10 Sri International C-glycosidic adriamycin analogs
US4591637A (en) * 1985-01-17 1986-05-27 Sri International Open chain-morpholino adriamycins
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) * 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5137877B1 (en) * 1990-05-14 1996-01-30 Bristol Myers Squibb Co Bifunctional linking compounds conjugates and methods for their production
GB9019933D0 (en) * 1990-09-12 1990-10-24 Erba Carlo Spa 13-dihydro-3'-(2-alkoxy-4-morphlinyl)anthracyclines
US5196522A (en) * 1990-11-01 1993-03-23 Board Of Regents, The University Of Texas System Anthracycline analogues bearing latent alkylating substituents
US5843903A (en) * 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
WO2001049698A1 (en) * 1999-12-29 2001-07-12 Immunogen, Inc. Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
US20080132458A1 (en) * 2004-03-10 2008-06-05 Threshold Pharmaceuticals, Inc. Hypoxia-Activated Anti-Cancer Agents
US20070060534A1 (en) * 2005-06-30 2007-03-15 Threshold Pharmaceuticals, Inc. Anthracycline analogs
CA2721140C (en) * 2008-04-11 2016-02-09 Tianjin Hemay Bio-Tech Co. Ltd. Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof
RU2013103763A (ru) 2010-07-02 2014-08-10 Ангиохем Инк. Короткие и содержащие d-аминокислоты полипептиды для терапевтических конъюгатов и их применения
EP3191134B1 (de) 2014-09-12 2019-11-20 Genentech, Inc. Anthracyclindisulfidzwischenprodukte, antikörper-wirkstoff-konjugate und verfahren
EP4180061A1 (de) 2021-11-10 2023-05-17 Nerviano Medical Sciences S.r.l. Linker-reagenzien für anthracyclinderivate, antikörper-arznemittelkonjugate und verfahren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109076A (en) * 1977-09-08 1978-08-22 Sri International 5-iminodaunomycin
US4202967A (en) * 1978-10-02 1980-05-13 Sri International N,N-pentamethylene derivatives of daunomycin and adriamycin
US4301277A (en) * 1980-10-20 1981-11-17 Sri International 3-Deamino-3-(4-morpholinyl) derivatives of daunorubicin and doxorubicin
US4314054A (en) * 1981-03-23 1982-02-02 Sri International 3'-Deamino-3'-(4-methoxy-1-piperidinyl) derivatives of daunorubicin and doxorubicin

Also Published As

Publication number Publication date
ES524271A0 (es) 1984-11-16
SE8304045L (sv) 1984-01-21
IT8322143A1 (it) 1985-01-20
DE3325816A1 (de) 1984-01-26
YU140585A (en) 1986-02-28
GR78885B (de) 1984-10-02
AU1694683A (en) 1984-01-26
IE55795B1 (en) 1991-01-16
KR880002461B1 (ko) 1988-11-14
DK332983A (da) 1984-01-21
NZ204911A (en) 1986-04-11
IT8322143A0 (it) 1983-07-20
IE831680L (en) 1984-01-20
NO832610L (no) 1984-01-23
ES8501415A1 (es) 1984-11-16
US4464529A (en) 1984-08-07
BE897312A (fr) 1984-01-18
NO157146C (no) 1988-01-27
GB2124224A (en) 1984-02-15
CH655729A5 (de) 1986-05-15
PT77060A (en) 1983-08-01
YU155083A (en) 1986-02-28
FI75174B (fi) 1988-01-29
IL69260A (en) 1987-03-31
DE3325816C2 (de) 1990-05-03
PH21860A (en) 1988-03-25
ES8602032A1 (es) 1985-11-01
CA1239396A (en) 1988-07-19
GB2124224B (en) 1985-12-04
KR840005443A (ko) 1984-11-12
SE8304045D0 (sv) 1983-07-19
FI75174C (fi) 1988-05-09
IL69260A0 (en) 1983-11-30
ES530593A0 (es) 1985-11-01
DK332983D0 (da) 1983-07-19
ATA260883A (de) 1986-02-15
GB8319165D0 (en) 1983-08-17
SE459921B (sv) 1989-08-21
AU555902B2 (en) 1986-10-16
PT77060B (en) 1986-04-09
DK158269C (da) 1990-10-08
FR2530640A1 (fr) 1984-01-27
IT1163818B (it) 1987-04-08
FI832637A0 (fi) 1983-07-19
FR2530640B1 (fr) 1985-07-12
NO157146B (no) 1987-10-19
NL188905C (nl) 1992-11-02
DK158269B (da) 1990-04-23
NL8302586A (nl) 1984-02-16
FI832637A (fi) 1984-01-21

Similar Documents

Publication Publication Date Title
AT381319B (de) Verfahren zur herstellung von neuen derivaten von daunorubicin und doxorubicin
AT381934B (de) Verfahren zur herstellung von neuen indolderivaten und ihren salzen
ATA129184A (de) Verfahren zur herstellung von neuen phenaethanolaminverbindungen und ihren salzen und solvaten
AT385506B (de) Verfahren zur herstellung von neuen carbostyrilderivaten und deren salzen
AT374449B (de) Verfahren zur herstellung von neuen basischen aethern und deren salzen
AT372390B (de) Verfahren zur herstellung von neuen 4'-jodderivaten von anthracyclinglykosiden
ATA404284A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT379804B (de) Verfahren zur herstellung von neuen phenaethylimidazolderivaten und von deren salzen
AT371465B (de) Verfahren zur herstellung von neuen 2-azaergolinen und 2-aza-8(oder 9)-ergolenen
AT374450B (de) Verfahren zur herstellung von neuen propanolaminderivaten und deren salzen
AT384810B (de) Verfahren zur herstellung von psoralenfreien neuen 6-alkylangelicinen und von deren salzen
ATA238481A (de) Verfahren zur herstellung von neuen acylaminophenylpyridinderivaten und deren salzen
ATA106084A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
AT382615B (de) Verfahren zur herstellung von neuen substituierten thiamorpholinonderivaten und deren sulfoxiden
AT362060B (de) Verfahren zur herstellung von neuen anti- biotika (a-40104)und derivaten davon
ATA284985A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ATA154183A (de) Verfahren zur herstellung von neuen imidazochinoxalinen und von deren salzen
ATA315781A (de) Verfahren zur herstellung von neuen pyridinylaminophenolen und deren salzen
AT366665B (de) Verfahren zur herstellung von neuen n-isothioureido-phthalimiden und deren salzen
ATA497081A (de) Verfahren zur herstellung von neuen 3-aminosubstituierten steroidderivaten und von deren salzen
ATA90386A (de) Verfahren zur herstellung von neuen substituierten thiamorpholinonderivaten und deren sulfoxiden
AT386410B (de) Verfahren zur herstellung von neuen ergolinderivaten
ATA298486A (de) Verfahren zur herstellung von neuen imidazochinoxalinen und ihren salzen
DD237511A1 (de) Verfahren zur herstellung von neuen pregnenderivaten und ihren stereoisomeren

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee